Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brooks

Showing results (911-920 of 928) with videos related to

Pageof 93
Sort By:
The Lancet. Infectious Diseases|November 10, 2024
Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30Amanda E Semper, Janie Olver, Jenny Warner, et al.
Immunity|February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunityKebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Iscience|August 19, 2024
Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infectionLisa M Arkin, Ana C Costa-da-Silva, Justin Frere, et al.
Translational Oncology|June 22, 2026
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC studyRachel L Delahunty, Madawa Jayawardana, Rainier Arnolda, et al.
Disability and Rehabilitation|February 11, 2020
Identifying priorities and developing strategies for building capacity in amputation research in CanadaSander L Hitzig, Amanda L Mayo, Ahmed Kayssi, et al.
The Journal of Experimental Medicine|August 26, 2022
CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cellsMichael N T Souter, Wael Awad, Shihan Li, et al.
The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Science (New York, N.Y.)|October 31, 2024
Cation reactivity inhibits perovskite degradation in efficient and stable solar modulesYong Ding, Bin Ding, Pengju Shi, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Pageof 93

Showing results (911-920 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Infectious Diseases|November 10, 2024
Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30Amanda E Semper, Janie Olver, Jenny Warner, et al.
Immunity|February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunityKebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Iscience|August 19, 2024
Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infectionLisa M Arkin, Ana C Costa-da-Silva, Justin Frere, et al.
Translational Oncology|June 22, 2026
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC studyRachel L Delahunty, Madawa Jayawardana, Rainier Arnolda, et al.
Disability and Rehabilitation|February 11, 2020
Identifying priorities and developing strategies for building capacity in amputation research in CanadaSander L Hitzig, Amanda L Mayo, Ahmed Kayssi, et al.
The Journal of Experimental Medicine|August 26, 2022
CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cellsMichael N T Souter, Wael Awad, Shihan Li, et al.
The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Science (New York, N.Y.)|October 31, 2024
Cation reactivity inhibits perovskite degradation in efficient and stable solar modulesYong Ding, Bin Ding, Pengju Shi, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Pageof 93